ArticleBone marrow transplantation2025

Chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma: a real-world experience.

Bhavesh Mohan Lal et al.PubMed ↗Publisher ↗

No numbers read from the abstract.